Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [15436]

ASH 2018: Concurrent ibrutinib may improve outcomes, reduce toxicity of CAR T-Cell Therapy with JCAR014 for CLL

ASH 2018: Concurrent ibrutinib may improve outcomes, reduce toxicity of CAR T-Cell Therapy with JCAR014 for CLL

ASH 2018: Tisagenlecleucel continues to show durable remissions in kids and young adults with stubborn form of leukaemia

ASH 2018: Tisagenlecleucel continues to show durable remissions in kids and young adults with stubborn form of...

ASH 2018: CAR T-Cell therapies show durable responses, new research also explores combination therapies to extend and enhance treatment responses

ASH 2018: CAR T-Cell therapies show durable responses, new research also explores combination therapies to extend...

$ASH 2018: Alvocidib shows encouraging activity in patients with MCL-1 dependent relapsed or refractory AML$

ASH 2018: Alvocidib shows encouraging activity in patients with MCL-1 dependent relapsed or refractory AML

Altering cancer metabolism helps treatments attack tumours

Altering cancer metabolism helps treatments attack tumours

Nanoscale blood test technique set to springboard cancer discoveries

Nanoscale blood test technique set to springboard cancer discoveries

Cryoablation shows promise in treating low-risk breast cancers

Cryoablation shows promise in treating low-risk breast cancers

New study supports mammography screening at 30 for some women

New study supports mammography screening at 30 for some women

Study identifies a genetic driver of deadly prostate cancer

Study identifies a genetic driver of deadly prostate cancer

Researchers identify 'Achilles heel' of drug-resistant tumours

Researchers identify 'Achilles heel' of drug-resistant tumours

More from ecancer